Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» India Rejects Gilead Patent Bid for Sovaldi Hepatitis C Treatment
India Rejects Gilead Patent Bid for Sovaldi Hepatitis C Treatment
India Rejects Gilead Patent Bid for Sovaldi Hepatitis C Treatment
Submitted by
admin
on January 15, 2015 - 8:59am
Source:
WSJ Pharmalot
News Tags:
India
patents
Gilead Sciences
Sovaldi
hepatitis C
Headline:
India Rejects Gilead Patent Bid for Sovaldi Hepatitis C Treatment
Do Not Allow Advertisers to Use My Personal information
